PREVENTIVE ANTIEPILEPTIC THERAPY IN PATIENTS WITH TUBEROUS SCLEROSIS

Background. Early detection of epileptiform activity on the electroencephalogram (EEG) and preventive antiepileptic therapy in patients with tuberous sclerosis (TS) help to avoid the development of severe forms of epilepsy as well as cognitive disorders associated with it.Materials and methods. Seve...

Full description

Bibliographic Details
Main Authors: A. V. Grigoryeva, M. Yu. Dorofeeva, Z. K. Gorchkhanova, V. S. Perminov, E. D. Belousova
Format: Article
Language:Russian
Published: ABV-press 2017-08-01
Series:Русский журнал детской неврологии
Subjects:
Online Access:https://rjdn.abvpress.ru/jour/article/view/210
_version_ 1797874493213900800
author A. V. Grigoryeva
M. Yu. Dorofeeva
Z. K. Gorchkhanova
V. S. Perminov
E. D. Belousova
author_facet A. V. Grigoryeva
M. Yu. Dorofeeva
Z. K. Gorchkhanova
V. S. Perminov
E. D. Belousova
author_sort A. V. Grigoryeva
collection DOAJ
description Background. Early detection of epileptiform activity on the electroencephalogram (EEG) and preventive antiepileptic therapy in patients with tuberous sclerosis (TS) help to avoid the development of severe forms of epilepsy as well as cognitive disorders associated with it.Materials and methods. Seventeen patients with TS underwent preventive antiepileptic treatment in the Research and Clinical Institute for Pediatrics named after Y.E Vel’tishev. All patients were diagnosed with TS during their first months of life. The diagnosed was based on the detection of cardiac rhabdomyomas and hypopigmentation spots and then confirmed by a genetic test. Antiepileptic drugs (AED) (vigabatrin in 7 patients, valproic acid in 7 patients and levetiracetam in 2 patients) were administered after detection of epileptiform activity in the routine EEG (EEG was performed monthly).Results. Preventive therapy with valproic acid and levetiracetam was found to be ineffective: 4 out of 7 patients on valproic acid and 1 out of 2 patients on levetiracetam developed epilepsy. All of them were later diagnosed with delayed psychological development and delayed speech development. Among 7 patients receiving vigabatrin, only 1 patient developed epilepsy, but did not have any developmental disorders later.Conclusion. Despite vigabatrin is not registered in the Russian Federation, it should be used as an agent for preventive antiepileptic therapy in patients with TS. This approach ensures more favorable long-term results in terms of cognitive functions and psychological development, thus, providing a better quality of life.
first_indexed 2024-04-10T01:31:54Z
format Article
id doaj.art-b71390b66f954af88600245bca3ecafe
institution Directory Open Access Journal
issn 2073-8803
2412-9178
language Russian
last_indexed 2024-04-10T01:31:54Z
publishDate 2017-08-01
publisher ABV-press
record_format Article
series Русский журнал детской неврологии
spelling doaj.art-b71390b66f954af88600245bca3ecafe2023-03-13T09:30:12ZrusABV-pressРусский журнал детской неврологии2073-88032412-91782017-08-01122343910.17650/2073-8803-2017-12-2-34-39151PREVENTIVE ANTIEPILEPTIC THERAPY IN PATIENTS WITH TUBEROUS SCLEROSISA. V. Grigoryeva0M. Yu. Dorofeeva1Z. K. Gorchkhanova2V. S. Perminov3E. D. Belousova4ГБОУ ВПО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава РоссииГБОУ ВПО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава РоссииГБОУ ВПО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава РоссииГБОУ ВПО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава РоссииГБОУ ВПО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава РоссииBackground. Early detection of epileptiform activity on the electroencephalogram (EEG) and preventive antiepileptic therapy in patients with tuberous sclerosis (TS) help to avoid the development of severe forms of epilepsy as well as cognitive disorders associated with it.Materials and methods. Seventeen patients with TS underwent preventive antiepileptic treatment in the Research and Clinical Institute for Pediatrics named after Y.E Vel’tishev. All patients were diagnosed with TS during their first months of life. The diagnosed was based on the detection of cardiac rhabdomyomas and hypopigmentation spots and then confirmed by a genetic test. Antiepileptic drugs (AED) (vigabatrin in 7 patients, valproic acid in 7 patients and levetiracetam in 2 patients) were administered after detection of epileptiform activity in the routine EEG (EEG was performed monthly).Results. Preventive therapy with valproic acid and levetiracetam was found to be ineffective: 4 out of 7 patients on valproic acid and 1 out of 2 patients on levetiracetam developed epilepsy. All of them were later diagnosed with delayed psychological development and delayed speech development. Among 7 patients receiving vigabatrin, only 1 patient developed epilepsy, but did not have any developmental disorders later.Conclusion. Despite vigabatrin is not registered in the Russian Federation, it should be used as an agent for preventive antiepileptic therapy in patients with TS. This approach ensures more favorable long-term results in terms of cognitive functions and psychological development, thus, providing a better quality of life.https://rjdn.abvpress.ru/jour/article/view/210эпилепсиятуберозный склероздетивигабатринпревентивная терапия
spellingShingle A. V. Grigoryeva
M. Yu. Dorofeeva
Z. K. Gorchkhanova
V. S. Perminov
E. D. Belousova
PREVENTIVE ANTIEPILEPTIC THERAPY IN PATIENTS WITH TUBEROUS SCLEROSIS
Русский журнал детской неврологии
эпилепсия
туберозный склероз
дети
вигабатрин
превентивная терапия
title PREVENTIVE ANTIEPILEPTIC THERAPY IN PATIENTS WITH TUBEROUS SCLEROSIS
title_full PREVENTIVE ANTIEPILEPTIC THERAPY IN PATIENTS WITH TUBEROUS SCLEROSIS
title_fullStr PREVENTIVE ANTIEPILEPTIC THERAPY IN PATIENTS WITH TUBEROUS SCLEROSIS
title_full_unstemmed PREVENTIVE ANTIEPILEPTIC THERAPY IN PATIENTS WITH TUBEROUS SCLEROSIS
title_short PREVENTIVE ANTIEPILEPTIC THERAPY IN PATIENTS WITH TUBEROUS SCLEROSIS
title_sort preventive antiepileptic therapy in patients with tuberous sclerosis
topic эпилепсия
туберозный склероз
дети
вигабатрин
превентивная терапия
url https://rjdn.abvpress.ru/jour/article/view/210
work_keys_str_mv AT avgrigoryeva preventiveantiepileptictherapyinpatientswithtuberoussclerosis
AT myudorofeeva preventiveantiepileptictherapyinpatientswithtuberoussclerosis
AT zkgorchkhanova preventiveantiepileptictherapyinpatientswithtuberoussclerosis
AT vsperminov preventiveantiepileptictherapyinpatientswithtuberoussclerosis
AT edbelousova preventiveantiepileptictherapyinpatientswithtuberoussclerosis